You are here: Industry Insights > Medicine

News List

Top 10 Research Fronts in Medicine in 2018 Muzi
December 13, 2018
Cancer Therapies including PD-1/PD-L1 Inhibitors, etc. Being the “Hottest”
Pharma agrees to 2% cap on branded meds growth pharmatimes
November 26, 2018
The Association of the British Pharmaceutical Industry has agreed the terms of the 2019 Pharmaceutical Price Regulation Scheme (PPRS) with the government, which is expected to come into effect from January.
Online Tool Helps Patients With Advance Care Planning drugs
November 14, 2018
Online Tool Helps Patients With Advance Care Planning
Link between early antibiotic exposure and weight gain in young children europeanpharmaceuticalreview
November 05, 2018
A recent study has shown that antibiotics use in young children (under 24 months) could result in weight gain shown when the child reaches the age of 5…
AstraZeneca Agrees to Divest Nexium, Vimovo Rights to Grünenthal americanpharmaceuticalreview
October 31, 2018
AstraZeneca has agreed to divest the prescription medicine rights to Nexium (esomeprazole) in Europe, as well as the global rights (excluding the US and Japan) to Vimovo (naproxen/esomeprazole) to Grünenthal. The medicines are outside
Continually evolving solid dosage forms expressbpd
October 31, 2018
Solid dosage forms are a preferred option of drug administration. But, deployment of novel materials and new age manufac
Roche aims to improve cancer treatments with DNA blood test pharmaphorum
September 27, 2018
Roche has launched a blood test that can identify 70 of the most commonly mutated genes in solid tumours, as the company seeks to make more medicine more personalised.
AZ grabs EU approval for Imfinzi in advanced lung cancer pharmaphorum
September 27, 2018
The European Commission has approved AstraZeneca’s immunotherapy drug Imfinzi (durvalumab) in a kind of lung cancer that was previously only treatable with chemotherapy.
Aevi Genomic Medicine Announces Novel Co-crystal Version of AEVI-001 americanpharmaceuticalreview
July 24, 2018
Aevi Genomic Medicine has received positive feedback from the United States Food and Drug Administration (FDA) on an improved version of the company's lead development molecule, AEVI-001, identified as AEVI-004.
Roche buys out rest of Foundation Medicine for $2.4bn pharmafile
June 22, 2018
Roche has clearly seen significant potential in Foundation Medicine’s work in genomics to pay $2.4 billion to take complete ownership of the company.

Previous page 1 2 3 4 5 6 7 8 9 Next page